XOMA Corporation Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Financial Statements Detail (Tables)

Condensed Consolidated Financial Statements Detail (Tables)

9 Months Ended

Sep. 30, 2019

Condensed Consolidated Financial Statements Detail [Abstract]

Accrued and other liabilities consisted of the following (in thousands):

	September 30,		December 31,
	2019		2018
Accrued legal and accounting fees	$	315	$	396
Accrued restructuring		—		1,361
Accrued incentive compensation		294		152
Accrued payroll and other benefits		282		155
Other		209		318
Total	$	1,100	$	2,382

Reconciliation of Numerator and Denominator Used in Calculation of Basic and Diluted Net Income (Loss) per Share Available to Common Stockholders

The following is a reconciliation of the numerator (net income or loss) and the denominator (number of shares) used in the calculation of basic and diluted net income (loss) per share available to common stockholders (in thousands):

	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
Numerator
Net income (loss)	$	3,178		$	(4,578	)	$	2,339		$	(10,331	)
Less: Allocation of undistributed earnings to participating securities		(1,327	)		—			(977	)		—
Net income (loss) available to common stockholders, basic		1,851			(4,578	)		1,362			(10,331	)
Add: Adjustments to undistributed earnings allocated to participating securities		60			—			41			—
Net income (loss) available to common stockholders, diluted	$	1,911		$	(4,578	)	$	1,403		$	(10,331	)

Denominator
Weighted average shares used in computing basic net income (loss) per share available to common stockholders		8,731			8,386			8,721			8,354
Effect of dilutive stock options		708			—			657			—
Effect of dilutive warrants		2			—			1			—
Weighted average shares used in computing diluted net income (loss) per share available to common stockholders		9,441			8,386			9,379			8,354

Outstanding Securities Considered Anti-Dilutive

Potentially dilutive securities are excluded from the calculation of diluted net income (loss) per share available to common stockholders if their inclusion is anti-dilutive. The following table shows the weighted-average outstanding securities considered anti-dilutive and therefore excluded from the computation of diluted net income (loss) per share available to common stockholders (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2019		2018		2019		2018
Convertible preferred stock		—		5,003		—		5,003
Common stock options and RSUs		893		1,644		926		1,638
Warrants for common stock		15		24		15		21
Total		908		6,671		941		6,662